Innovative Strategies For Risk Reduction Following CABG

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

May 31, 2010

Conditions
Coronary Artery DiseaseType II Diabetes Mellitus
Interventions
BEHAVIORAL

Consumption of Dietary Portfolio

The study involves following an aggressive low fat diet that is high in viscous fiber, nuts and soy protein. The diet is individually tailored to meet individual participants needs.

Trial Locations (1)

M5B 1W8

St. Michael's Hospital, Toronto

All Listed Sponsors
collaborator

Canadian Diabetes Association

OTHER

lead

Unity Health Toronto

OTHER

NCT00462436 - Innovative Strategies For Risk Reduction Following CABG | Biotech Hunter | Biotech Hunter